Namenda

Ebixa / Namenda (memantine) belongs to the group of medicines known as NMDA receptor antagonists and is prescribed to treat moderate to severe Alzheimer’s disease.

Ebixa is not recommended for children and adolescents under the age of 18 years.

Dosage

The doctor will determine the dosage regimen. The usual dosage for adults and elderly patients is 20 mg daily.

To reduce the risk of side effects, this dose is achieved gradually, starting at 5 mg (half a tablet) per day in the first week, then increasing by 5 mg each week for three weeks until the full dose is reached.

If a higher dosage is taken in error, contact a doctor or seek medical help. Taking an overdose will usually not result in any harm but may cause increased side effects. If a child swallowed the medicine by mistake, refer immediately to the physician or a hospital emergency room and bring the package of medicine with.